Arrowstreet Capital
IMCR icon

Arrowstreet Capital’s Immunocore IMCR Stock Holding History

Arrowstreet Capital’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.26M Buy
+134,165
New +$3.97M ﹤0.01% 1339
2026
Q1 		– Sell
-33,579
Closed -$1.17M – 1972
2025
Q4 		$1.17M Buy
+33,579
New +$1.19M ﹤0.01% 1521
2023
Q1 		– Sell
-4,718
Closed -$269K – 1423
2022
Q4 		$269K Buy
+4,718
New +$266K ﹤0.01% 1230

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Arrowstreet Capital's IMCR Position: Q2 2026 in Review

Arrowstreet Capital opened a new position in Immunocore (IMCR) in Q2 2026: 134,165 shares worth $4.26M. The stake represents ﹤0.01% of the portfolio and ranks #1339 among its holdings. This is a return to the name: Arrowstreet Capital previously reported a position in IMCR as recently as Q4 2025.

Arrowstreet Capital first reported a position in IMCR in Q4 2022 and has held it in 3 quarters since. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Arrowstreet Capital held 134,165 shares of Immunocore worth $4.26M as of Q2 2026.
  • Immunocore was a new Arrowstreet Capital position in Q2 2026.
  • Immunocore made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1339 holding.
  • Arrowstreet Capital first reported a position in Immunocore in Q4 2022 and has held it in 3 quarters since.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.